Identification of drugs /degraded products/impurities/ polymer/ excipients/ in bulk drugs/formulated products Drug/Polymer compatibility/ impurity monitoring / separation and identification of impurities Bioanalytical / Analytical method development Validation and Risk assessment of Method and Analysis as per ICH guidelines (ICH Q14: Analytical Procedure Development and Revision of Q2(R1) Analytical Validation dated 14 November 2018).